What is Imatinib?

Category: Prescription Drugs

Most popular types: Gleevec

false

Imatinib is an antineoplastic agent which inhibits BCR-ABL tyrosine kinase, the abnormal gene product of the Philadelphia chromosome in chronic myeloid leukemia. It is also used for Ph+ acute lymphoblastic leukemia (ALL) and gastrointestinal stromal tumors (GIST).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Chronic myeloid leukemia 21 13
Gastrointestinal stromal tumors 8 3
Mast cell activation syndrome 2 1
Fluid retention (edema) 1 1
Giant cell tumor of the bone 1 0
Hypereosinophilic syndrome 1 1

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 3
Moderate 4
Mild 11
None 0

Commonly reported side effects and conditions associated with Imatinib

Side effect Patients Percentage
Diarrhea 7
Nausea 4
Elevated liver enzymes 2
Fatigue 2
Fluid retention (edema) 2
Rashes (redness, swelling) 2

Show all 24 reported side effects

Dosages

Based on patients currently taking Imatinib

Dosage Patients Percentage
400 mg daily 3
300 mg daily 1

Why patients stopped taking Imatinib

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 6
Doctor's advice 4
Did not seem to work 2
Other 1
See all 9 patients who've stopped taking Imatinib

Duration

Currently taking Imatinib

Duration Patients Percentage
2 - 5 years 2
5 - 10 years 1
10 years or more 1

Stopped taking Imatinib

Duration Patients Percentage
Less than 1 month 2
1 - 6 months 2
6 months - 1 year 3
1 - 2 years 2
2 - 5 years 1
Adherence
Adherence Evaluations Percentage
Always 17
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 4
Not at all hard to take 13
Cost per month
Cost per month Evaluations Percentage
$200+ 2
$100-199 1
$50-99 0
$25-49 7
< $25 2
Not specified 6

What people switch to and from

Patients started taking Imatinib after stopping:

Treatment Patients Percentage
Hydroxychloroquine (Plaquenil) 1
mepolizumab (Nucala) 1

Patients stopped taking Imatinib and switched to:

Treatment Patients Percentage
Dasatinib (Sprycel) 1
Nilotinib (Tasigna) 1
Sorafenib (Nexavar) 1
Last updated:
There are no evaluations for Imatinib.